GlycoMark to Pay $195,000 for Allegedly Continuing to Promote Ineligible Medicare Claims for Diabetes Test
GlycoMark, Inc.—a joint venture owned by Toyota Tsusho, its American subsidiary, and Nippon Kayaku—has agreed to pay $195,000 to resolve allegations that it encouraged customers to submit claims to Medicare and Medicaid for its hyperglycemia test after it was no longer approved for reimbursement.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year